Landrace added value and accessibility in Europe: what a collection of case studies tells us

In the actual climate change scenario, in situ conservation of plant genetic resources for food and agriculture can significantly contribute broadening the diversity of our food system as well as increasing its resilience; nevertheless, landrace cultivation has been dramatically reduced in the last decades all over Europe. One of the most effective approaches to counteract the loss of landrace diversity in situ is facilitating its use. Aims of this study were to (i) describe how in situ maintenance of landraces occurs in different agro-environmental conditions in Europe and (ii) identify the main factors influencing landrace added values and accessibility as means to increase their adoption by new farmers. To the purpose, a collection of 95 case studies of both garden and open field landraces maintained in situ was analysed. A first description was obtained by classifying the information into 18 purposely defined categories. Data on landraces added values and accessibility were further transformed into weighted variables; the derived quantitative scores were then used as dependent variables in univariate and multivariate analyses. Results showed that farmers alone are still the main actors maintaining landraces in situ across different European biogeographical regions, mainly carrying out their activity under organic or low-input conditions, often in marginal areas. Results of the multivariate analysis showed that (i) type of actor involved in the multiplication, (ii) the main use of the product and (iii) presence of promotion actions significantly affect garden landraces added value and accessibility; presence of promotion actions was the only factor affecting added value of open field entries. Evidence arising from this work can contribute to the establishment of a fruitful ground of discussion for future European policies and strategies to protect and increase landrace use

Newly described clinical and immunopathological feature of dermatitis herpetiformis.

Dermatitis herpetiformis (DH) is an inflammatory cutaneous disease with typical histopathological and immunopathological findings clinically characterized by intensely pruritic polymorphic lesions with a chronic-relapsing course. In addition to classic clinical manifestations of DH, atypical variants are more and more frequently reported and histological and immunological are added to them, whereas the impact on quality of life of patients with DH is increasingly important to a certain diagnosis. The aim of this paper is to describe all the possible clinical, histological, and immunological variants of DH in order to facilitate the diagnosis of a rare disease and, therefore, little known

Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement

Direct diagnosis of mucous membrane pemphigoid (MMP) is not easy. Circulating autoantibodies targeting bullous pemphigoid antigens of 180 kDa and 230 kDa (BP180 and BP230), \u3b16\u3b24 integrin, laminin 332 and type VII collagen (Col VII) are not always present. The aims of this study were to characterize the humoral immune response of a cohort of Italian patients with MMP, its association with clinical involvement and severity, and to design an algorithm for efficient serological diagnosis. Seventy-eight MMP sera were studied retrospectively by indirect immunofluorescence on salt-split skin, enzyme-linked immunosorbent assay (ELISA) and immunoblotting. Indirect immunofluorescence on salt-split skin resulted in the most sensitive approach for diagnosis of MMP. BP180 was the major autoantigen in MMP patients with oral and cutaneous involvement. Significant associations were found between BP180 reactivity and oral and cutaneous localization of the lesions (p\u2009=\u20090.006), and between Col VII positivity and Setterfield severity score (p\u2009=\u20090.020)

Accretion Discs with an Inner Spiral Density Wave

In Montgomery (2009a), we show that accretion discs in binary systems could retrogradely precess by tidal torques like the Moon and the Sun on a tilted, spinning, non-spherical Earth. In addition, we show that the state of matter and the geometrical shape of the celestial object could significantly affect the precessional value. For example, a Cataclysmic Variable (CV) Dwarf Novae (DN) non-magnetic system that shows negative superhumps in its light curve can be described by a retrogradely precessing, differentially rotating, tilted disc. Because the disc is a fluid and because the gas stream overflows the tilted disc and particles can migrate into inner disc annuli, coupled to the disc could be a retrogradely precessing inner ring that is located near the innermost annuli of the disc. However, numerical simulations by Bisikalo et al. (2003, 2004) and this work show that an inner spiral density wave can be generated instead of an inner ring. Therefore, we show that retrograde precession in non-magnetic, spinning, tilted CV DN systems can equally be described by a retrogradely precessing and differentially rotating disc with an attached retrogradely precessing inner spiral density wave so long as the wave appears at the same radius as the ring and within the plane of the tilted disc. We find that the theoretical results generated in this work agree well with the theoretical results presented in Montgomery (2009a) and thus with the numerical simulations and select CV DN systems in Montgomery (2009b) that may have a main sequence secondary. Therefore, pressure effects do need to be considered in CV DN systems that exhibit negative superhumps if the accretion discs are tilted and have an inner spiral density wave that is in the plane of the disc

Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma

The broad differential diagnosis of neonatal erythroderma often poses a diagnostic challenge. Mortality of neonatal erythroderma is high due to complications of the erythroderma itself and the occasionally severe and life-threatening underlying disease. Early correct recognition of the underlying cause leads to better treatment and prognosis. Currently, neonatal erythroderma is approached on a case-by-case basis. The purpose of this scoping review was to develop a diagnostic approach in neonatal erythroderma. After a systematic literature search in Embase (January 1990 - May 2020, 74 cases of neonatal erythroderma were identified, and 50+ diagnoses could be extracted. Main causes were the ichthyoses (40%) and primary immunodeficiencies (35%). Congenital erythroderma was present in 64% (47/74) of the cases, predominantly with congenital ichthyosis (11/11; 100%), Netherton syndrome (12/14, 86%) and Omenn syndrome (11/23, 48%). Time until diagnosis ranged from 102 days to 116 days for cases of non-congenital erythroderma and congenital erythroderma respectively. Among the 74 identified cases a total of 17 patients (23%) died within a mean of 158 days and were related to Omenn syndrome (35%), graft-versus-host disease (67%) and Netherton syndrome (18%). Disease history and physical examination are summarized in this paper. Age of onset and a collodion membrane can help to narrow the differential diagnoses. Investigations of blood, histology, hair analysis, genetic analysis and clinical imaging are summarized and discussed. A standard blood investigation is proposed, and the need for skin biopsies with lympho-epithelial Kazal-type related Inhibitor staining is highlighted. Overall, this review shows that diagnostic procedures narrow the differential diagnosis in neonatal erythroderma. A 6-step flowchart for the diagnostic approach for neonatal erythroderma during the first month of life is proposed. The approach was made with the support of expert leaders from international multidisciplinary collaborations in the European Reference Network Skin-subthematic group Ichthyosis.Peer reviewe

Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial

Objective: To assess the efficacy, safety and tolerability of sodium valproate (800. mg/die) compared with placebo in medication-overuse headache patients with a history of migraine without aura. Methods: This is a multicenter, randomized, double-blind, placebo-controlled study enrolled medication-overuse headache patients for a 3-month treatment period with sodium valproate (800. mg/day) or placebo after a 6 day outpatient detoxification regimen, followed by a 3-month follow-up. Primary outcome was defined by the proportion of patients achieving ≥50% reduction in the number of days with headache per month (responders) from the baseline to the last 4 weeks of the 3-month treatment. Multivariate logistic regression models were used on the primary endpoint, adjusting for age, sex, disease duration, comorbidity and surgery. The last-observation-carried-forward method was used to adjust for missing values. Results: Nine sites enrolled 130 patients and, after a 6-day detoxification phase, randomized 88 eligible patients. The 3-month responder rate was higher in the sodium valproate (45.0%) than in the placebo arm (23.8%) with an absolute difference of about 20% (p=0.0431). Sodium valproate had safety and tolerability profiles comparable to placebo. Conclusions: The present study supports the efficacy and safety of sodium valproate in the treatment of medication overuse headache with history of migraine after detoxification

Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies.

We retrospectively studied 132 patients with dermatomyositis; 84 had idiopathic, 30 paraneoplastic, 5 juvenile and 13 amyopathic forms of the disease. The commonest features were macular erythema, heliotropic erythema and Gottron's papules. Flagellate erythema occurred in 5% of patients with idiopathic dermatomyositis and correlated with the disease activity. Necrotic lesions were also found in this group of patients but did not always signal malignancy. The prevalence of malignancy was high (23%). Raynaud's phenomenon occurred in 10.6% of patients, also in those with malignancy. Dysphagia, interstitial lung disease and arthralgias affected 20%, 8% and 40% of patients, respectively. Anti-Jo-1 antibodies were found in 5% of patients with idiopathic dermatomyositis and low titre ANA in 1/3 of patients. ANA did not correlate with the disease activity. We confirmed the data from the literature, but no cutaneous sign, constitutional symptom or circulating antibody was found marking a particular subtype of the disease